Prostate cancer vaccine - YM BioSciences

Drug Profile

Prostate cancer vaccine - YM BioSciences

Alternative Names: Norelin; Prostate cancer vaccine - Biostar; Prostate cancer vaccine - Star Biotech; YMB2002

Latest Information Update: 20 Jan 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Star Biotech
  • Class Cancer vaccines
  • Mechanism of Action Gonadotropin releasing hormone inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Prostate cancer

Most Recent Events

  • 02 Jun 2005 Data from a media release have been added to the adverse events and Cancer therapeutic trials sections
  • 04 Mar 2005 The vaccine is available for licensing (http://www.ymbiosciences.com)
  • 12 Jun 2003 Data from a media release have been added to the adverse events and Cancer therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top